PTPI
Petros Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$0.00
+3.36%Next report
Analyst consensus
- Next report date
- Dec 2, 2026
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.30
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -676.4%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | — | -$0.30 | — | — |
| May 13, 2026 | — | -$0.03 | — | — |
| Nov 13, 2025 | — | -$0.03 | — | — |
| Aug 14, 2025 | — | -$1.58 | — | — |
| May 15, 2025 | — | -$8.46 | — | — |
| Mar 31, 2025 | -$8.25 | -$29 | Miss -251.52% | $725.4K |
| Aug 14, 2024 | -$0.77 | -$9.25 | Miss -1101.30% | $1.4M |
| May 31, 2024 | — | $0.13 | — | -$364.3K |
| Nov 15, 2023 | — | -$58 | — | $1.7M |
| Aug 14, 2023 | — | -$30 | — | $2.0M |
| May 15, 2023 | — | -$17 | — | $2.5M |
| Nov 15, 2022 | — | -$168 | — | -$1.5M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026